These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15710912)

  • 21. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations.
    Kats LM; Wang L; Murhandarwati EE; Mitri K; Black CG; Coppel RL
    Vaccine; 2008 Jun; 26(26):3261-7. PubMed ID: 18468741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.
    Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ
    Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
    Cao Y; Zhang DM; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passive transfer of Plasmodium falciparum MSP-2 pseudopeptide-induced antibodies efficiently controlled parasitemia in Plasmodium berghei-infected mice.
    Martínez PA; Yandar N; Lesmes LP; Forero M; Pérez-Leal O; Patarroyo ME; Lozano JM
    Peptides; 2009 Feb; 30(2):330-42. PubMed ID: 19071172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cloning and optimized prokaryotic expression of a pbmag-1 cDNA fragment from Plasmodium berghei ANKA].
    Gao YH; Wang H
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):314-9. PubMed ID: 18038803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene conjugation of molecular adjuvant C3d3 to hCGbeta increased the anti-hCGbeta Th2 and humoral immune response in DNA immunization.
    Wang XL; Zhao XR; Yu M; Yuan MM; Yao XY; Li DJ
    J Gene Med; 2006 Apr; 8(4):498-505. PubMed ID: 16389614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro.
    Blagborough AM; Sinden RE
    Vaccine; 2009 Aug; 27(38):5187-94. PubMed ID: 19596419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region.
    Das P; Grewal JS; Mahajan B; Chauhan VS
    Parasitol Int; 2007 Mar; 56(1):51-9. PubMed ID: 17258500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C3d enhanced DNA vaccination induced humoral immune response to glycoprotein C of pseudorabies virus.
    Tong T; Fan H; Tan Y; Xiao S; Ling J; Chen H; Guo A
    Biochem Biophys Res Commun; 2006 Sep; 347(4):845-51. PubMed ID: 16857165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.
    Lanar DE; Tine JA; de Taisne C; Seguin MC; Cox WI; Winslow JP; Ware LA; Kauffman EB; Gordon D; Ballou WR; Paoletti E; Sadoff JC
    Infect Immun; 1996 May; 64(5):1666-71. PubMed ID: 8613376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutating the anchor residues associated with MHC binding inhibits and deviates CD8+ T cell mediated protective immunity against malaria.
    Dobaño C; McTague A; Sette A; Hoffman SL; Rogers WO; Doolan DL
    Mol Immunol; 2007 Mar; 44(9):2235-48. PubMed ID: 17169429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
    Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
    Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
    Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural ordering of the
    Kucharska I; Thai E; Srivastava A; Rubinstein JL; Pomès R; Julien JP
    Elife; 2020 Nov; 9():. PubMed ID: 33253113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apical membrane antigen 1: a malaria vaccine candidate in review.
    Remarque EJ; Faber BW; Kocken CH; Thomas AW
    Trends Parasitol; 2008 Feb; 24(2):74-84. PubMed ID: 18226584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity.
    Kurtovic L; Drew DR; Dent AE; Kazura JW; Beeson JG
    Front Immunol; 2021; 12():775659. PubMed ID: 34925347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.